Crypto
Why Cardano Share Price Might Be on a Sharp Decline
Cardano’s price increased earlier this month, which was due to optimistic expectations of investors regarding this upgrade. The current decline might be related to the well-known concept of “Sell the News”. Cardano’s price has also fallen below the lines of the exponential moving averages of the last 25 and 50 days, while the Relative Strength Index (RSI) has risen slightly above the oversold level.
The price of Cardano (ADA) remains under pressure as investors awaited the Federal Reserve’s upcoming interest rate decision. ADA fell to a low of $0.4525, down about 15% from its high this month. It has since recovered somewhat to $0.4745. The total market capitalization is about $16 billion.
Read more about Cardano’s price and find the latest news in the crypto sector with the Born2Invest business news mobile app.
Vasil upgrade is imminent
Cardano, like other cryptocurrencies, is experiencing a sharp sell-off right now. One of the reasons is that investors are worried about the upcoming Federal Reserve rate hike.
The Federal Reserve started its two-day meeting on Tuesday and is expected to publish its decision today. Analysts expect the bank to raise interest rates for the second month in a row by another 0.75%.
Historically, cryptocurrencies tend to perform worse during a period of high-interest rates. This also explains why the prices of Bitcoin and other cryptocurrencies have fallen sharply this year.
Cardano’s price slide is happening despite the fact the hard fork upgrade, dubbed Vasil, is scheduled to happen over the next few weeks.
According to IOHK, the upgrade will bring significant performance and feature improvements to Cardano. Some of the key features that will be included are diffusion pipelining and upgrades to Plutus. Plutus is the programming language for smart contracts created on Cardano.
In addition, Cardano’s operators plan to introduce other features, such as reference inputs, that will improve data exchange on the chain. In addition, developers should be able to create scripts and append dates directly to outputs instead of using hashes in the future. It should also be possible to reference the scripts without including them in every transaction.
Cardano’s price increased earlier this month, which was due to optimistic expectations of investors regarding this upgrade. The current decline might be related to the well-known concept of “Sell the News”.
Cardano Price Forecast
On the chart, the ADA price has formed a double top, or the double top formation. In price action analysis, this pattern is usually a bearish sign. The current price is below the “chin” of the pattern at $0.4751.
Cardano’s price has also fallen below the lines of the exponential moving averages of the last 25 and 50 days, while the Relative Strength Index (RSI) has risen slightly above the oversold level.
__
(Featured image by Michael Fortsch via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CRYPTO MONDAY, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Rovi Cuts Its Profit by 4% in the First Nine Months, to 113.5 Million
-
Biotech4 days ago
Better Care Advances Healthcare Technology with Partnership with Oracle
-
Fintech1 week ago
Fintech Company Satispay Raises 60 Million Euros Led by Addition
-
Biotech2 days ago
ATB Therapeutics Raises €54 Million and Attracts a Pharmaceutical Giant